Selective desensitization of the 5‐HT4 receptor‐mediated response in pig atrium but not in stomach

Background and purpose:  The time dependency of the effect of 5‐HT4 receptor agonists depends on many specific regulatory mechanisms, which vary between tissues. This has important implications with regard to the effects of endogenous 5‐HT, as well as to the clinical use of 5‐HT4 receptor agonists,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2009-01, Vol.156 (2), p.362-376
Hauptverfasser: De Maeyer, JH, Schuurkes, JAJ, Lefebvre, RA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose:  The time dependency of the effect of 5‐HT4 receptor agonists depends on many specific regulatory mechanisms, which vary between tissues. This has important implications with regard to the effects of endogenous 5‐HT, as well as to the clinical use of 5‐HT4 receptor agonists, and might contribute to tissue selectivity of agonists. Experimental approach:  The progression and desensitization of 5‐HT4 receptor‐mediated responses were evaluated in an organ bath set‐up using two, clinically relevant, porcine in vitro models: gastric cholinergic neurotransmission and atrial contractility. Key results:  Exposure of gastric tissue to 5‐HT or to the selective 5‐HT4 receptor agonists prucalopride and M0003 results in a sustained non‐transient effect during exposure; after washout, the response to a subsequent challenge with 5‐HT shows no clear desensitization. Incubation of left atrial tissue with 5‐HT resulted in a transient response, leading after washout to a marked desensitization of the subsequent response to 5‐HT. The selective 5‐HT4 receptor agonists prucalopride and M0003 induce only very weak atrial responses whereas they are very effective in desensitizing the atrial response to 5‐HT. The observations also suggest that the properties of prucalopride and M0003 to bind to and/or activate the 5‐HT4 receptor differ from those of 5‐HT. This difference might have contributed to the observed desensitization. Conclusions and implications:  The high potency of prucalopride and M0003 in desensitizing the response to 5‐HT together with their low efficacy in the atrium emphasizes the cardiac safety of this class of 5‐HT4 receptor agonists.
ISSN:0007-1188
1476-5381
DOI:10.1111/j.1476-5381.2008.00007.x